Showing 61 - 80 results of 86 for search '"Influenza vaccine"', query time: 0.06s Refine Results
  1. 61
  2. 62

    An Aloe-Based Composition Constituting Polysaccharides and Polyphenols Protected Mice against D-Galactose-Induced Immunosenescence by Mesfin Yimam, Teresa Horm, Alexandria O’Neal, Ping Jiao, Mei Hong, Qi Jia

    Published 2024-01-01
    “…All mice were given a quadrivalent influenza vaccine at 3 µg/animal via intramuscular injection 14 days before the end of the study. …”
    Get full text
    Article
  3. 63

    Vaccination status of individuals with diabetes mellitus treated in Primary Healthcare: a cross-sectional study by Francisco João de Carvalho Neto, Luisa Helena de Oliveira Lima, Mônica Antar Gamba, Rosilane Lima de Brito, Lucilane Maria Sales da Silva, Ana Roberta Vilarouca da Silva

    Published 2025-02-01
    “…A statistically significant association was found between sociodemographic and clinical profile regarding the full vaccination schedule between the influenza vaccine and age and income; COVID-19 and age, type of diabetes and duration of diabetes. …”
    Get full text
    Article
  4. 64

    COVID-19 vaccination attitudes and acceptance among people with serious mental illness by William Small, Caroline Silva, Rachel Johnson, Vincent Betti, Antoinette Nguyen, Lauren Todd, David Jacobowitz, J. Steven Lamberti

    Published 2025-01-01
    “…Participants who reported having received an influenza vaccine in the past two years were more likely to be vaccinated (80.2%) than those who had not (41.8%). …”
    Get full text
    Article
  5. 65

    Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association... by Tiago Alfaro, Filipe Froes, Cláudia Vicente, Rui Costa, Cristina Gavina, Rui Baptista, António Maio, Saraiva da Cunha, João Sérgio Neves, Pedro Leuschner, Sofia Duque, Paula Pinto

    Published 2025-12-01
    “…The vaccine should preferably be given between September and November and can be co-administered with the influenza vaccine. Ongoing studies on RSV vaccines may justify extending these recommendations in the future.…”
    Get full text
    Article
  6. 66

    Ex Vivo Restimulation of Human PBMC Expands a CD3+CD4-CD8-γδ+ T Cell Population That Can Confound the Evaluation of CD4 and CD8 T Cell Responses to Vaccination by B. J. Sedgmen, L. Papalia, L. Wang, A. R. Dyson, H. A. McCallum, C. M. Simson, M. J. Pearse, E. Maraskovsky, D. Hung, P. P. Eomois, G. Hartel, M. J. Barnden, S. P. Rockman

    Published 2013-01-01
    “…During the assessment of cell-mediated immunity (CMI) in subjects participating in a large-scale influenza vaccine trial, we identified the expansion of an IFN-γ-producing CD3+CD4-CD8-γδ+ T cell population in the peripheral blood of 90/610 (15%) healthy subjects. …”
    Get full text
    Article
  7. 67

    Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I by Yukitoshi Takahashi, Kazumi Matsuda, Yuko Kubota, Jiro Shimomura, Etsuko Yamasaki, Tatsuya Kudo, Katsuyuki Fukushima, Hitoshi Osaka, Noriyuki Akasaka, Atsushi Imamura, Shinji Yamada, Naomi Kondo, Tateki Fujiwara

    Published 2006-01-01
    “…In a patient with seizure onset after influenza A infections, cross-reaction of the patient's lymphocytes with GluRε2 and influenza vaccine components was demonstrated by lymphocyte stimulation test. …”
    Get full text
    Article
  8. 68

    Attitude to RSV Vaccination Among a Cohort of Pregnant Women in Jordan: A Cross‐Sectional Survey Study by Malik Sallam, Tleen Kherfan, Amwaj Al‐Farajat, Leen Nemrawi, Nada Atawneh, Rand Fram, Ala'a B. Al‐Tammemi, Muna Barakat, Kamil Fram

    Published 2025-01-01
    “…Variables that were significantly associated with a higher RSV vaccine acceptance in multivariate analysis were: age < 30 years (adjusted odds ratio (aOR): 2.45, p = 0.010), undergraduates (aOR: 3.27, p = 0.026), being a healthcare worker (aOR: 4.50, p = 0.036), and the history of previous COVID‐19/influenza vaccine uptake (aOR: 2.47, p = 0.045). Two out of the six ABCDEF constructs were significantly associated with RSV vaccine acceptance, namely the “Advice” construct (aOR: 10.38, p < 0.001) and the “Fear” construct (aOR: 21.49, p < 0.001). …”
    Get full text
    Article
  9. 69

    Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza by Olivia Prosper, Omar Saucedo, Doria Thompson, Griselle Torres-Garcia, Xiaohong Wang, Carlos Castillo-Chavez

    Published 2010-12-01
    “…The challenges faced by nations dealing jointly with seasonal and novel A-H1N1 co-circulating strains under limited resources, that is, those with no access to novel A-H1N1 vaccine supplies, limited access to the seasonal influenza vaccine, and limited access to antivirals (like Tamiflu) are explored in this study. …”
    Get full text
    Article
  10. 70

    Delivery of dendritic cells targeting 3M2e-HA2 nanoparticles with a CpG adjuvant via lysosomal escape of Salmonella enhances protection against H9N2 avian influenza virus by Futing Jia, Wenfeng Wang, Yawen Tian, Ainul Zahra, Yingkai He, Chongbo Ge, Tongyu Zhang, Mingyue Wang, Jingshuo Gong, Gerui Zhang, Guilian Yang, Wentao Yang, Chunwei Shi, Jianzhong Wang, Haibin Huang, Xin Cao, Yang Zeng, Nan Wang, Zhannan Wang, Chunfeng Wang, Yanlong Jiang

    Published 2025-01-01
    “…Avian influenza virus (AIV) subtype H9N2 still poses a great threat to the poultry farming industry and public health worldwide, and the development of a new influenza vaccine that is safe and conservative and able to address influenza virus mutations is highly promising for application. …”
    Get full text
    Article
  11. 71

    Postinfluenza Vaccination Idiopathic Thrombocytopenic Purpura in Three Elderly Patients by Joji Nagasaki, Masahiro Manabe, Kentaro Ido, Hiroyoshi Ichihara, Yasutaka Aoyama, Tadanobu Ohta, Yoshio Furukawa, Atsuko Mugitani

    Published 2016-01-01
    “…We report the cases of three elderly patients who developed ITP after receiving influenza vaccinations. The platelet count of an 81-year-old woman fell to 27,000/μL after she received an influenza vaccination. …”
    Get full text
    Article
  12. 72

    Should My Patient with Inflammatory Bowel Disease on Immunosuppressive Therapy be Vaccinated against Influenza Virus? by Neeraj Narula, Deborah LR Yamamura, John K Marshall

    Published 2010-01-01
    “…Current research suggests that inactivated influenza vaccines are effective, well tolerated and can be administered safely in most IBD patients. …”
    Get full text
    Article
  13. 73

    Herpes zoster vaccine and the risk of stroke: a population-based cohort study using linked data from the Clinical Practice Research Datalink by Fawziah Marra, Kathryn Richardson, Helen I McDonald, Yoon Kong Loke, Helen Mary Parretti

    Published 2024-04-01
    “…The active comparator comprised 653 373 adults receiving an influenza vaccination between 2013 and 2019 meeting herpes zoster vaccine eligibility. …”
    Get full text
    Article
  14. 74

    Limited preventive care among Medicaid enrollees with HIV in the US South by Jessica S. Kiernan, Rose S. Bono, Deo Mujwara, Zhongzhe Pan, Bassam Dahman, April D. Kimmel

    Published 2025-01-01
    “…Enrollees received lipid, syphilis, and cervical cancer screenings and influenza vaccination in < 50% and glucose screening in 71.7% of total enrollment-years. …”
    Get full text
    Article
  15. 75
  16. 76

    Post-Vaccination Anaphylaxis in Adults: A Systematic Review and Meta-Analysis by Flavia Pennisi, Anna Carole D’Amelio, Rita Cuciniello, Stefania Borlini, Luigi Mirzaian, Giovanni Emanuele Ricciardi, Massimo Minerva, Vincenza Gianfredi, Carlo Signorelli

    Published 2025-01-01
    “…Most studies focused on influenza vaccines (<i>n</i> = 15). Across all studies, 262 anaphylactic cases were reported, with 153 cases related to influenza vaccines, followed by herpes zoster virus vaccines (38 cases) and yellow fever vaccines (29 cases). …”
    Get full text
    Article
  17. 77

    Routine Immunization of Adults in Canada: Review of the Epidemiology of Vaccine-Preventable Diseases and Current Recommendations for Primary Prevention by Michael D Parkins, Shelly A McNeil, Kevin B Laupland

    Published 2009-01-01
    “…All adult Canadians with significant medical comorbidities or those older than 65 years of age should receive the pneumococcal polysaccharide vaccine and yearly trivalent inactivate influenza vaccines. The present review summarizes the burden of illness of these vaccine-preventable diseases in the Canadian adult population and reviews the current immunization recommendations. …”
    Get full text
    Article
  18. 78
  19. 79

    The Expression of IL-6, TNF-α, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease by Jingtong Zheng, Yue Shi, Lingxin Xiong, Weijie Zhang, Ying Li, Peter G. Gibson, Jodie L. Simpson, Chao Zhang, Junying Lu, Jingying Sai, Guoqiang Wang, Fang Wang

    Published 2017-01-01
    “…Additionally, VP patients were less likely to have received influenza vaccination. VP patients had a systemic inflammation response involving IL-6, TNF-α, and MCP-1 which may be due to virus-induced activation of macrophages. …”
    Get full text
    Article
  20. 80

    Rapid aging of influenza epidemics in China from 2005/06 to 2016/17: A population-based study by Weibo Tang, Hao Lei, Nan Zhang, Yaojing Wang, Shimeng Cai, Shuyi Ji, Lei Yang, Mengya Yang, Can Chen, Shigui Yang, Dayan Wang, Yuelong Shu

    Published 2025-06-01
    “…This finding highlights the importance of influenza vaccination among older individuals in China.…”
    Get full text
    Article